Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects.

This study aimed to identify any association of serum nitric oxide (NO) and advanced glycation end products (AGEs) with body mass index (BMI) in apparently healthy subjects. In this cross-sectional study, participants were 90 apparently healthy subjects, categorized into three BMI groups as follows:...

Full description

Bibliographic Details
Main Authors: Elaheh Foroumandi, Mohammad Alizadeh, Sorayya Kheirouri, Mohammad Asghari Jafarabadi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0213307
_version_ 1819115105077428224
author Elaheh Foroumandi
Mohammad Alizadeh
Sorayya Kheirouri
Mohammad Asghari Jafarabadi
author_facet Elaheh Foroumandi
Mohammad Alizadeh
Sorayya Kheirouri
Mohammad Asghari Jafarabadi
author_sort Elaheh Foroumandi
collection DOAJ
description This study aimed to identify any association of serum nitric oxide (NO) and advanced glycation end products (AGEs) with body mass index (BMI) in apparently healthy subjects. In this cross-sectional study, participants were 90 apparently healthy subjects, categorized into three BMI groups as follows: BMI≤19.5 (n = 21), 19.6≤BMI≤24.9 (n = 35), and BMI≥25 (n = 34). Serum levels of NO were measured by griess reaction method. Determination of serum pentosidine and carboxymethyllysine (CML) was done using ELISA. Median (95% confidence interval [CI]: lower- upper) of serum NO in subjects with BMI≥25 were 68.94 (CI: 55.01-70.56) μmol/L, which was higher compared with 19.6≤BMI≤24.9 and BMI≤19.5 groups (22.65 (CI: 19.29-28.17) μmol/L and 8.00 (CI: 9.12-29.58) μmol/L, respectively). Serum NO positively correlated with BMI in total subjects (r = 0.585, p<0.001), which this correlation was significant in both male and female groups (r = 0.735, p<0.001 and r = 0.476, p = 0.001, respectively). Serum pentosidine and CML were significantly lower in subjects with higher BMI. Further, BMI showed negative correlations with pentosidine and CML (r = -0.363, p<0.001 and r = -0.484, p<0.001, respectively). There were not any significant differences in serum NO, pentosidine, and CML levels between sex groups. After adjusting the effects of confounders (BMI, sex, age, and waist to hip ratio), serum NO significantly correlated with serum pentosidine and CML (r = -0.319, p = 0.003 and r = -0.433, p<0.001, respectively). It is concluded that higher BMI is accompanied by increased serum NO and suppressed pentosidine and CML.
first_indexed 2024-12-22T04:55:54Z
format Article
id doaj.art-31514d47940d4d47aa466816a07c0724
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T04:55:54Z
publishDate 2019-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-31514d47940d4d47aa466816a07c07242022-12-21T18:38:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01143e021330710.1371/journal.pone.0213307Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects.Elaheh ForoumandiMohammad AlizadehSorayya KheirouriMohammad Asghari JafarabadiThis study aimed to identify any association of serum nitric oxide (NO) and advanced glycation end products (AGEs) with body mass index (BMI) in apparently healthy subjects. In this cross-sectional study, participants were 90 apparently healthy subjects, categorized into three BMI groups as follows: BMI≤19.5 (n = 21), 19.6≤BMI≤24.9 (n = 35), and BMI≥25 (n = 34). Serum levels of NO were measured by griess reaction method. Determination of serum pentosidine and carboxymethyllysine (CML) was done using ELISA. Median (95% confidence interval [CI]: lower- upper) of serum NO in subjects with BMI≥25 were 68.94 (CI: 55.01-70.56) μmol/L, which was higher compared with 19.6≤BMI≤24.9 and BMI≤19.5 groups (22.65 (CI: 19.29-28.17) μmol/L and 8.00 (CI: 9.12-29.58) μmol/L, respectively). Serum NO positively correlated with BMI in total subjects (r = 0.585, p<0.001), which this correlation was significant in both male and female groups (r = 0.735, p<0.001 and r = 0.476, p = 0.001, respectively). Serum pentosidine and CML were significantly lower in subjects with higher BMI. Further, BMI showed negative correlations with pentosidine and CML (r = -0.363, p<0.001 and r = -0.484, p<0.001, respectively). There were not any significant differences in serum NO, pentosidine, and CML levels between sex groups. After adjusting the effects of confounders (BMI, sex, age, and waist to hip ratio), serum NO significantly correlated with serum pentosidine and CML (r = -0.319, p = 0.003 and r = -0.433, p<0.001, respectively). It is concluded that higher BMI is accompanied by increased serum NO and suppressed pentosidine and CML.https://doi.org/10.1371/journal.pone.0213307
spellingShingle Elaheh Foroumandi
Mohammad Alizadeh
Sorayya Kheirouri
Mohammad Asghari Jafarabadi
Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects.
PLoS ONE
title Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects.
title_full Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects.
title_fullStr Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects.
title_full_unstemmed Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects.
title_short Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects.
title_sort exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects
url https://doi.org/10.1371/journal.pone.0213307
work_keys_str_mv AT elahehforoumandi exploringtheroleofbodymassindexinrelationshipofserumnitricoxideandadvancedglycationendproductsinapparentlyhealthysubjects
AT mohammadalizadeh exploringtheroleofbodymassindexinrelationshipofserumnitricoxideandadvancedglycationendproductsinapparentlyhealthysubjects
AT sorayyakheirouri exploringtheroleofbodymassindexinrelationshipofserumnitricoxideandadvancedglycationendproductsinapparentlyhealthysubjects
AT mohammadasgharijafarabadi exploringtheroleofbodymassindexinrelationshipofserumnitricoxideandadvancedglycationendproductsinapparentlyhealthysubjects